Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Jurisdiction: The state where your lawsuit is filed (e.g., North Carolina or Florida for our firm's services) can also influence certain filing fees and procedural costs
Other Indications Under Study Type 2 Diabetes (TRANSCEND-T2D) TRANSCEND-T2D-1 was the first Phase 3 readout in type 2 diabetes, with Lilly reporting results on March 19, 2026
We publish no figure for it, because no clinical source gives one
The difference may partly reflect dose equivalency issues in trials rather than a true pharmacological difference
US$ 27.74
US$ 25.64
US$ 27.93
